Hanjing Xie, Chief Medical Officer at Oncorena AB, shared a post on LinkedIn:
“Excited to start as Chief Medical Officer at Oncorena AB.
It’s prime time for oncology, and I’m thrilled to work with a first-in-class drug candidate with real potential to make a difference.
Innovation in medicine has always been a passion of mine, and improving patient outcomes remains my driving force in the fight against cancer.
Grateful for the journey so far-and motivated by the work ahead.”
Other articles on OncoDaily.